Out-of-pocket costs of oral anticancer drugs for Medicare beneficiaries vary by strength and formulation

J Geriatr Oncol. 2023 Jan;14(1):101386. doi: 10.1016/j.jgo.2022.10.001. Epub 2022 Oct 11.
No abstract available

Keywords: Medication pricing; Oral drugs; Proportion.

Publication types

  • Letter

MeSH terms

  • Aged
  • Antineoplastic Agents*
  • Health Expenditures
  • Humans
  • Medicare
  • Prescription Drugs*
  • United States

Substances

  • Antineoplastic Agents
  • Prescription Drugs